Biomarker-driven therapies in oncology

Building on the success of its previous editions, this course explores the latest advancements in molecular diagnostics and genomics, with a focus on their practical application in oncology. 

A significant emphasis is placed on breast cancer, examining its pathology and the use of molecular and multigene testing to support clinical decision-making. Real-life case discussions further enhance participants’ understanding of how to effectively integrate these tools into practice.

The programme extends its scope to other cancer types, investigating key biomarkers and their impact on personalised treatment strategies. Expert-led discussions provide invaluable guidance on the clinical relevance of molecular diagnostics, while interactive sessions foster active audience engagement. This approach ensures participants gain a well-rounded and actionable understanding of genomics in modern cancer care.

 

• Understand the fundamental principles of biomarker determination 

• Appreciate the importance of preanalytical aspects in biomarker determination

• Be familiar with ESMO guidelines

• Know the key biomarkers used in the management of breast cancer and gynaecological cancers and understand their role in clinical decision-making

• Understand the application of biomarkers in the management of other cancer types

• Discuss the role of agnostic biomarkers 

• Be informed about the latest advances concerning biomarkers in oncology, notably through the sponsored symposia

 

 

The course is held entirely in English and fluency in English is necessary for admission.